Avenue Biosciences raised a $5.7M seed extension co-led by Balnord and Tesi, joined by Voima Ventures, Inventure, University of Helsinki, and Dimerent.
02 January 2026
02 January 2026
Total investments received (USD): 8.2M
Round value (USD): 5.7M
Company: Avenue Biosciences
Related deals
Trince in a $6M equity deal backed by qbic and Novalis in Belgium
Investments
16 December 2026
EnteroBiotix to raise $5.3 million
Investments
01 April 2026
Peptomyc raised €5M with Alta Life Sciences, Aurora Science et al
Investments
01 April 2026
Iteria Biopharma in a €5 million Series Seed funding round led by Inveready, Xesgalicia
Investments
16 March 2026
Gradientech raises SEK 49.2 million
Investments
14 March 2026
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
France
Ireland
Portugal